Nanoparticle-Loaded Transdermal Patches: An Emerging Strategy for the Management of Hyperuricemia

Gouty arthritis is a chronic inflammatory disorder resulting from monosodium urate crystal deposition, necessitating long-term management with uric acid-lowering and anti-inflammatory drugs. Conventional therapies, including allopurinol and febuxostat, face limitations such as poor bioavailability, gastrointestinal side effects, and rapid clearance, which reduce therapeutic efficacy. Nanoparticle-based transdermal drug delivery systems have emerged as a promising alternative, offering controlled and targeted drug release while minimizing systemic toxicity. Lipid-based nanocarriers, polymeric nanoparticles, carbon nanotubes, and nanocellulose derivatives have been extensively investigated for enhancing drug solubility, permeability, and sustained release. Functionalized multi-walled carbon nanotubes, CNT-gold nanoparticle composites, and CNT-hydrogel hybrids have demonstrated improved skin penetration, biocompatibility, and electro-responsive drug release profiles. Similarly, nanocellulose-based carriers, including bacterial nanocellulose, cellulose nanofibers, and cellulose nanocrystals, exhibit high mechanical strength, biocompatibility, and effective sustained release, making them suitable for transdermal applications. Despite these advantages, challenges remain in clinical translation, including nanoparticle stability, fusion, lipid polymorphism, sterilization difficulties, and regulatory hurdles related to safety and cytotoxicity. Strategies such as lyophilization, stabilizing agents, and careful material selection are being explored to overcome these limitations. Preclinical and early clinical studies indicate that nanoparticle-loaded transdermal patches can enhance therapeutic outcomes, reduce adverse effects, and provide patient-friendly administration, highlighting their potential as next-generation platforms for gout management. Continued research and rigorous clinical evaluation are required to optimize formulation design, ensure safety, and facilitate regulatory approval for widespread clinical application.